Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medical therapy for acute ischemic stroke.

L B Goldstein1

  • 1Duke Center for Cerebrovascular Disease, Stroke Policy Program, Center for Clinical Health Policy Research, Duke University Medical Center, Box 3651, Durham, NC 27710, USA. golds004@mc.duke.edu

Current Atherosclerosis Reports
|June 8, 2001
PubMed
Summary

Recent advancements in acute ischemic stroke treatment include thrombolytic therapy with intravenous tissue plasminogen activator and intra-arterial agents. Effective medical management significantly impacts patient outcomes, even without thrombolysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secondary preventive medication persistence and adherence 1 year after stroke.

Neurology·2011
Same author

Effects of bilateral and unilateral locus coeruleus lesions on beam-walking recovery after subsequent unilateral sensorimotor cortex suction-ablation in the rat.

Restorative neurology and neuroscience·2011
Same author

Post-lesion practice and amphetamine-facilitated recovery of beam-walking in the rat.

Restorative neurology and neuroscience·2011
Same author

Norepinephrine depletion impairs motor recovery following sensorimotor cortex injury in the rat.

Restorative neurology and neuroscience·2011
Same author

Acute unilateral sensorimotor cortex injury in the rat blocks d-amphetamine induced norepinephrine release in cerebellum.

Restorative neurology and neuroscience·2011
Same author

Outcomes after ischemic stroke for hospitals with and without Joint Commission-certified primary stroke centers.

Neurology·2011

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Emergency Medicine

Background:

  • Acute ischemic stroke treatment has seen significant data growth over the last decade.
  • Intravenous tissue plasminogen activator has transformed stroke care.
  • Emerging intra-arterial thrombolytic therapies are under investigation and used compassionately.

Purpose of the Study:

  • To review the current landscape of acute ischemic stroke treatments.
  • To highlight the impact of both thrombolytic and medical management strategies.
  • To inform on the evolving therapeutic options for stroke patients.

Main Methods:

  • Literature review of recent studies on acute ischemic stroke.
  • Analysis of data on thrombolytic therapies (intravenous and intra-arterial).

Related Experiment Videos

  • Evaluation of the role of medical management in stroke outcomes.

    • Main Results:

    • Intravenous thrombolysis is a revolutionary treatment for acute ischemic stroke.
    • Intra-arterial thrombolytic agents show promise and are used in specific cases.
    • Medical management is crucial and affects outcomes even in non-thrombolysed patients.

    Conclusions:

    • The treatment of acute ischemic stroke has rapidly evolved with new data.
    • Both advanced thrombolytic strategies and comprehensive medical management are key.
    • Further research and application of these therapies can improve patient prognosis.